Bill Newman

Bill Newman is managing director at Northwest Technology Ventures, an Oregon seed fund focused on finding and funding technology-based startups from the research sector. Prior to launching NTV, Bill's career started in academe before moving to entrepreneurial business and venture capital.

Bill earned a Ph.D. in mechanical engineering and applied mathematics prior to joining the research faculty at MIT, where he served for more than a decade as a principal investigator on NIH-funded research and directed a joint program at MIT and the Harvard Medical School to develop and evaluate technology for the treatment of cancer. Discoveries from that research resulted in patented inventions that he licensed from MIT to found a spinout that developed medical monitoring instrumentation. After earning an MBA from MIT, he joined Shaw Ventures in Portland, and subsequently launced NTV, a $14 million seed venture fund.

Bill currently holds four patents in the areas of medical and measurement instrumentation and is the author of numerous articles for technical journals and professional conferences. He also serves on numerous corporate boards, and on various academic and civic boards including Oregon's Higher Education Technology Transfer Fund Board and the Oregon Council on Knowledge and Economic Development.